Cases emphasize critical issues in diabetes: pathophysiology and progression; pharmacologic and nonpharmacologic strategies; as well as cultural diversity in care.
Review the features of these diseases and discuss the use of NSAIDs, DMARDs, and TNF-alpha antagonists in patients to help find the most successful treatments.
A discussion of the new treatment options in cholesterol and triglyceride management and the importance of controlling risks in patients with metabolic syndrome and elevated triglycerides. Medscape Family Medicine
Substantial progression to metabolic syndrome occurs within 3 years of initiating ART and therefore evaluation of risk should be carried out in patients commencing ART. AIDS
A study shows that individuals who regularly participate in sports activities have a lower risk for deep venous thrombosis and pulmonary embolism vs those who do not. Medscape Medical News
Carolyn Clancy, MD, Director of the Agency for Healthcare Research and Quality in Rockville, Maryland, explains how we can get our patients more involved in their care. Medscape General Medicine
The FDA has approved first-time generic formulations for oxcarbazepine tablets in 150-, 300-, and 600-mg strengths; hydrocodone
bitartrate and ibuprofen tablets in a 2.5-mg/200-mg strength; and rivastigmine tartrate capsules in 1.5-, 3-, 4.5-, and 6-mg (base) strengths. Medscape Medical News
A study suggests that patients who undergo total hip replacement report a noticeable long-term improvement in physical functioning, whereas age-matched population controls decline in function. Medscape Medical News
